Last reviewed · How we verify
Humira — clinical trials
Key trials
- Efficacy of Different Biological Treatments in Patients With Inflammatory Bowel Disease After One Year of Treatment in Upper Egypt
- Subconjunctival Humira for Boston Keratoprosthesis · PHASE1
- Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission · NA
- Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases · PHASE1, PHASE2
- Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis · PHASE3
- Treatment Tapering in JIA With Inactive Disease · PHASE3
- Preventing Structural Damage in Early Psoriatic Arthritis · PHASE4
- A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis · PHASE3
- A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease · PHASE4
- The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
- Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis · PHASE3
- A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes · PHASE1, PHASE2
See also
- Full profile: Humira
- Side effects: /side-effects
- Dosage & administration: /dosage
- Mechanism of action: /mechanism
- Cost & pricing: /cost
- Drug interactions: /interactions
- Patents & exclusivity: /patents
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing